- Home
- REPL vs ASPI Comparison
REPL vs ASPI Comparison
Compare REPL & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ASPI
- Stock Information
- Founded
- REPL 2015
- ASPI 2021
- Country
- REPL United States
- ASPI United States
- Employees
- REPL 479
- ASPI N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- REPL Health Care
- ASPI Industrials
- Exchange
- REPL Nasdaq
- ASPI Nasdaq
- Market Cap
- REPL 239.0M
- ASPI 653.4M
- IPO Year
- REPL 2018
- ASPI 2022
- Fundamental
- Price
- REPL $3.15
- ASPI $10.47
- Analyst Decision
- REPL Buy
- ASPI Strong Buy
- Analyst Count
- REPL 10
- ASPI 2
- Target Price
- REPL $8.25
- ASPI $7.75
- AVG Volume (30 Days)
- REPL 9.2M
- ASPI 4.5M
- Earning Date
- REPL 08-07-2025
- ASPI 08-18-2025
- Dividend Yield
- REPL N/A
- ASPI N/A
- EPS Growth
- REPL N/A
- ASPI N/A
- EPS
- REPL N/A
- ASPI N/A
- Revenue
- REPL N/A
- ASPI $4,405,477.00
- Revenue This Year
- REPL N/A
- ASPI $512.64
- Revenue Next Year
- REPL N/A
- ASPI $181.15
- P/E Ratio
- REPL N/A
- ASPI N/A
- Revenue Growth
- REPL N/A
- ASPI 245.97
- 52 Week Low
- REPL $2.68
- ASPI $1.86
- 52 Week High
- REPL $17.00
- ASPI $10.82
- Technical
- Relative Strength Index (RSI)
- REPL 24.82
- ASPI 66.00
- Support Level
- REPL $2.68
- ASPI $9.00
- Resistance Level
- REPL $3.85
- ASPI $10.69
- Average True Range (ATR)
- REPL 0.80
- ASPI 0.85
- MACD
- REPL -1.03
- ASPI 0.25
- Stochastic Oscillator
- REPL 4.45
- ASPI 91.67
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.